- 4009 Hackney Springs Ln, Sachse, TX 75048
Virginia’s MFCU has a history of pursuing high‑stakes fraud, with the HDL kickback case—disguised “processing fees” for referrals—serving as a clear warning for labs. Enforcement is only intensifying in 2026, with AI‑driven analytics flagging suspicious billing patterns almost instantly and genetic testing schemes drawing top federal attention. The False Claims Act and Anti‑Kickback Statute mean per‑test payments, inflated fees, or volume‑based commissions can trigger severe penalties.
To stay safe, labs must audit referral arrangements against fair market value, separate marketing pay from test orders, and thoroughly document medical necessity. Partnering with a Virginia‑focused lab billing company, like TransLabs, keeps coding and compliance practices aligned with current regulations, helping your lab avoid the traps that turned HDL’s rapid growth into a $114 million judgment.
You might be wondering how a single state fraud unit ended up connected to one of the largest corporate criminal resolutions in U.S. history. It’s an interesting case.
The thing is that Virginia’s Medicaid Fraud Control Unit (MFCU) has quietly built a reputation as one of the most effective fraud-fighting units, which has historically recovered over $2 billion through its investigations.
Its most famous case was the $650 million McKinsey & Co. resolution, which involved opioid marketing advice. Even though the case was unrelated to lab billing, it did speak volumes about how MFCU pursues big targets. Clinical labs and lab billing companies must pay close attention to the situation.
If you’re exploring options to stay clean at the time of MFCU investigations, we’ll guide you through helpful tips, discuss Virginia’s biggest fraud cases, and discuss how using clean and compliant Virginia laboratory billing services protects your lab.
The Virginia Medicaid Fraud Control Unit (MFCU) is a specialized division within the state Attorney General’s office. It investigates and prosecutes Medicaid provider fraud, along with patient abuse and neglect in health care settings.
MFCU, considered the nation’s toughest enforcement unit, stands out because:
A history of running major cases shows that MFCU knows how to build a case, work with federal partners, and investigate in-depth to detect and penalize complicated fraud.
In December 2024, MFCU played a huge part in a $650 million resolution with McKinsey & Company, the global consulting firm. McKinsey admitted that it helped misbrand OxyContin and destroyed records during its partnership with a pharmaceutical company. The purpose was to help boost sales for the pain-relieving medicine.
The scale of this case was so big that it made up 52% of MFCU recoveries across the nation in fiscal year 2025, as per the 2025 Medicaid Fraud Control Units Annual Report published by the Office of Inspector General under the Department of Health and Human Services.
You might be wondering why we’re discussing it if it’s not a lab billing case. This builds context and is a reminder that if any laboratory or company in Virginia is indicted of fraud, it’s prone to investigations.
Health Diagnostic Laboratory (HDL), a Richmond-based cardiovascular blood-testing lab, was once one of the city’s fastest-growing companies. It pulled in $139 million from Medicare in 2012 and $157 million in 2013. But then things started to change.
The thing is that HDL paid referring physicians a $20 processing and handling fee for every blood sample they sent in. It’s just like a routine administrative charge. In reality, federal investigators called it a kickback, designed to buy referrals rather than pay for legitimate handling costs.
This is a complete timeline of the case in the table below:
| Milestone | Detail |
|---|---|
| Alleged scheme | $10 to $20 "processing fees" paid to doctors per referred blood test |
| Initial settlement (2015) | $47 million, later capped up to $100 million with contingencies |
| Individual liability | Former CEO and two marketing executives found jointly liable |
| Final judgment | $114.1 million against three individuals after trial |
| False claims proven | Nearly 39,000 false claims tied to HDL and Singulex |
| Company outcome | HDL filed for Chapter 11 bankruptcy |
The reason for lab kickbacks is that labs are able to earn good money. They pay physicians who refer patients to them and are able to get a good number of patients for that. And this is why kickbacks appeal to laboratories.
To combat that, the federal government took some steps. In 2014, the HHS Department issued a Special Fraud Alert, which highlighted the pattern of labs rewarding compensation to physicians. It also laid down the rules, such as the Anti-Kickback Statute, to prohibit labs and physicians from participating in such practices. This is what led to HDL being targeted.
While you’re running a lab in Virginia, it’s important to note what regulators see as red flags to target laboratories:
If your billing or referral relationships fall within that criteria, it’s important to use laboratory billing audit services to review your billing practices against regulatory compliance. With that, you can make sure you’re on the right side of compliance and also know if there are any corrections to be made on your part.
In June 2026, the Department of Justice ran its largest health care fraud takedown ever, charging 455 defendants across 45 states and territories in schemes worth more than $6.5 billion. Genetic testing fraud was a headline category, with two accused fraudsters, one tied to a $547 million scheme and another to a $90 million scheme, landing on the FBI’s Most Wanted Fraudsters list after fleeing the country.
A few things stand out about how enforcement works now compared to even a few years ago:
It indicates that the systems that catch fraud work much faster than the fraudulent schemes that operate. For labs, especially across the state of Virginia, it’s important to use fair billing practices to prevent strict enforcement.
Here are a few practical ways that help your Virginia lab stay compliant with federal and state laws:
Virginia’s MFCU has built its reputation on going after complicated, high-dollar fraud, whether that’s a pharmaceutical consulting firm or a blood-testing lab paying doctors under the table. The HDL case remains the clearest lab-specific warning: kickbacks dressed up as “processing fees” eventually get noticed, and when they do, the fallout hits the company and the individuals who signed off on it.
With 2026 enforcement moving faster and smarter than ever, the labs that come out ahead are the ones that treat compliance as a part of their daily operations. A little diligence now beats a federal court indictment later, every time.